DUSA Pharmaceuticals Inc.
25 Upton Drive
Wilmington,
MA 01887
United States - Map
Phone: 978-657-7500
Fax: 978-657-9193
Web Site: http://www.dusapharma.com
| DUSA Pharmaceuticals, Inc., an integrated dermatology pharmaceutical company, develops and markets Levulan photodynamic therapy (PDT) and other products for common skin conditions in the United States and internationally. Its products include Levulan Kerastick 20% Topical Solution with PDT and the BLU-U brand light source for the treatment of non-hyperkeratotic actinic keratoses of the face or scalp. The BLU-U is used without Levulan to treat moderate inflammatory acne vulgaris and general dermatological conditions. The company is also developing non-PDT drug products, including Nicomide, Nicomide-T, AVAR products, ClindaReach, Meted, and Psoriacap products. DUSA Pharmaceuticals, Inc. was founded in 1991 and is based in Wilmington, Massachusetts. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Robert F. Doman M.D, 59
Chief Exec. Officer, Pres |
$
558.00K |
$
0 | Mr. Richard C. Christopher , 39
Chief Financial Officer, Principal Accounting Officer and VP of Fin. |
$
297.00K |
$
0 | Dr. Stuart L. Marcus M.D, Ph.D, 62
Chief Medical Officer and VP of Scientific Affairs |
$
354.00K |
$
0 | Mr. William F. O'Dell , 62
Exec. VP of Sales & Marketing |
$
333.00K |
$
0 | Mr. Scott L. Lundahl , 50
VP of Intellectual Property & Regulatory Affairs |
$
261.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.20% Nasdaq 
Profile
